NASDAQ: TMCITreace Medical Concepts Inc Stock Ownership - Who owns Treace Medical Concepts?
Insider buying vs selling
Have Treace Medical Concepts Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sean F. Scanlan | Chief Innovation Officer | 2025-07-18 | 33,437 | $0.72 | $24.01kBuy |
| Scot Michael Elder | Chief Legl Comp Off CorpSec | 2025-05-08 | 1,894 | $7.54 | $14.28kSell |
| Sean F. Scanlan | Chief Innovation Officer | 2025-03-17 | 50,000 | $1.05 | $52.50kBuy |
| Sean F. Scanlan | Chief Innovation Officer | 2025-03-17 | 50,000 | $7.97 | $398.45kSell |
| John T. Treace | Chief Executive Officer | 2025-03-04 | 60,000 | $8.73 | $524.04kBuy |
| Scot Michael Elder | Chief Legl Comp Off CorpSec | 2024-11-11 | 3,787 | $8.29 | $31.39kSell |
TMCI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TMCI insiders and whales buy or sell their stock.
TMCI Shareholders
What type of owners hold Treace Medical Concepts Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John T. Treace | 40.48% | 25,570,243 | $163.14M | Insider |
| Armistice Capital LLC | 9.91% | 6,260,000 | $39.94M | Institution |
| Thomas E. Timbie | 6.39% | 4,033,795 | $25.74M | Insider |
| John R. Treace | 6.13% | 3,870,043 | $24.69M | Insider |
| Blackrock Inc | 5.96% | 3,766,658 | $24.03M | Institution |
| James T. Treace | 5.08% | 3,208,570 | $20.47M | Insider |
| William Blair Investment Management LLC | 4.91% | 3,099,895 | $19.78M | Institution |
| Vanguard Group Inc | 4.31% | 2,725,240 | $17.39M | Institution |
| Gagnon Securities LLC | 3.56% | 2,250,148 | $14.36M | Institution |
| Jpmorgan Chase Co | 2.81% | 1,777,212 | $11.34M | Institution |
TMCI vs Medical Device Stocks
Treace Medical Concepts Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.